Dengue infection. (Q42996339)

12 November 2017

1 reference

title

Dengue infection. (English)

1 reference

12 November 2017

0 references

2

Duane J Gubler

0 references

Scott B Halstead

5

0 references

author name string

Maria G Guzman

1

1 reference

12 November 2017

Alienys Izquierdo

3

1 reference

12 November 2017

Eric Martinez

4

1 reference

12 November 2017

Scott B Halstead

5

1 reference

12 November 2017

18 August 2016

1 reference

Nature Reviews Disease Primers

12 November 2017

1 reference

12 November 2017

2

1 reference

12 November 2017

16055

1 reference

https://scigraph.springernature.com/pub.10.1038/nrdp.2016.55

12 November 2017

0 references

cites work

Dengue, Urbanization and Globalization: The Unholy Trinity of the 21(st) Century

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The global distribution and burden of dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Global spread of dengue virus types: mapping the 70 year history

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Economic impact of dengue illness in the Americas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The global economic burden of dengue: a systematic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A ligand-binding pocket in the dengue virus envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Conformational changes of the flavivirus E glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Antigenic structure of flavivirus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Flavivirus NS1 Structures Reveal Surfaces for Associations with Membranes and the Immune System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Human dendritic cells as targets of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Human skin Langerhans cells are targets of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Flavivirus cell entry and membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The human antibody response to dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Recognition determinants of broadly neutralizing human antibodies against dengue viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Epidemiologic studies on Dengue in Santiago de Cuba, 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Reduced risk of disease during postsecondary dengue virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue in Vietnamese Infants—Results of Infection‐Enhancement Assays Correlate with Age‐Related Disease Epidemiology, and Cellular Immune Responses Correlate with Disease Severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Clinical and Virological Features of Dengue in Vietnamese Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue 1 virus and dengue hemorrhagic fever, French Polynesia, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A Protective Role for Dengue Virus-Specific CD8+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Superior infectivity for mosquito vectors contributes to competitive displacement among strains of dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Susceptibility of larval Aedes aegypti and Aedes albopictus (Diptera: Culicidae) to dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Microevolution and virulence of dengue viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue virus-mosquito interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Controversies in dengue pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Quantitative aspects of replication of dengue viruses in Aedes albopictus (Diptera: Culicidae) after oral and parenteral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Selection-driven evolution of emergent dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Natural attenuation of dengue virus type-2 after a series of island outbreaks: a retrospective phylogenetic study of events in the South Pacific three decades ago.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Emergence and global spread of a dengue serotype 3, subtype III virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Invited commentary: Dengue lessons from Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Virus role during intraepidemic increase in dengue disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Race: a risk factor for dengue hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

HLA class I and II polymorphisms in Mexican Mestizo patients with dengue fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Protective and Enhancing HLA Alleles, HLA-DRB1*0901 and HLA-A*24, for Severe Forms of Dengue Virus Infection, Dengue Hemorrhagic Fever and Dengue Shock Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Immunopathogenesis of dengue hemorrhagic fever and shock syndrome: role of TAP and HPA gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Effect of age on outcome of secondary dengue 2 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Assessment of body fluid compartment volumes by multifrequency bioelectrical impedance spectroscopy in children with dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Early clinical and laboratory indicators of acute dengue illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Size and charge characteristics of the protein leak in dengue shock syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

HEMATODEPRESSIVE VIRUS DISEASES OF THAILAND.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The Potential Pathogenic Role of Complement in Dengue Hemorrhagic Shock Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of the World Health Organization standard tourniquet test and a modified tourniquet test in the diagnosis of dengue infection in Viet Nam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Hospital based clinical surveillance for dengue haemorrhagic fever in Bandung, Indonesia 1994-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue haemorrhagic fever in children in the 1996 Delhi epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The impact of dengue haemorrhagic fever on liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Molecular mimicry between virus and host and its implications for dengue disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Autoimmunity in dengue pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

High plasma mid-regional pro-adrenomedullin levels in children with severe dengue virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Hemostatic changes in Vietnamese children with mild dengue correlate with the severity of vascular leakage rather than bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue vascular permeability syndrome: what, no T cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Diagnosis of dengue: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of immunoglobulin M and G capture enzyme-linked immunosorbent assay Panbio kits for diagnostic dengue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue: a continuing global threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue: an update for clinicians working in non-endemic areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The predictive diagnostic value of serial daily bedside ultrasonography for severe dengue in Indonesian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Prediction of dengue disease severity among pediatric Thai patients using early clinical laboratory indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Use of simple clinical and laboratory predictors to differentiate influenza from dengue and other febrile illnesses in the emergency room

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Comparing the usefulness of the 1997 and 2009 WHO dengue case classification: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dogma in classifying dengue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of the traditional and revised WHO classifications of Dengue disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

An evaluation of the World Health Organization's 1997 and 2009 dengue classifications in hospitalized dengue patients in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Accuracy and applicability of the revised WHO classification (2009) of dengue in children seen at a tertiary healthcare facility in northern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of the 2009 WHO dengue case classification in an Indonesian pediatric cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Prospective applicability study of the new dengue classification system for clinical management in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of the WHO classification of dengue disease severity during an epidemic in 2011 in the state of Ceará, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

WHO dengue case classification 2009 and its usefulness in practice: an expert consensus in the Americas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Utilities and limitations of the World Health Organization 2009 warning signs for adult dengue severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Timing, predictors, and progress of third space fluid accumulation during preliminary phase fluid resuscitation in adult patients with dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The revised WHO dengue case classification: does the system need to be modified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of the NS1 rapid test and the WHO dengue classification schemes for use as bedside diagnosis of acute dengue fever in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Implications of discordance in world health organization 1997 and 2009 dengue classifications in adult dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue research funded by the European Commission-scientific strategies of three European dengue research consortia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

[Preventing deaths from dengue: a space and challenge for primary health care].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Recent advances in dengue pathogenesis and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue Hemorrhagic Fever: The Sensitivity and Specificity of the World Health Organization Definition for Identification of Severe Cases of Dengue in Thailand, 1994–2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Regarding "Dengue--How Best to Classify It"

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Review of dengue virus and the development of a vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue virus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Efficacy of a tetravalent dengue vaccine in children in Latin America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Antibodies from patients with dengue viral infection mediate cellular cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Live attenuated tetravalent dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Overlapping local and long-range RNA-RNA interactions modulate dengue virus genome cyclization and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A single dose of the DENV-1 candidate vaccine rDEN1Δ30 is strongly immunogenic and induces resistance to a second dose in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Protective and immunological behavior of chimeric yellow fever dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of extracellular subviral particles of dengue virus type 2 and Japanese encephalitis virus produced by Spodoptera frugiperda cells for use as vaccine and diagnostic antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Serotype specificity of recombinant fusion protein containing domain III and capsid protein of dengue virus 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The emergence of epidemic dengue fever and dengue hemorrhagic fever in the Americas: a case of failed public health policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Health protection in a shrinking world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue prevention and 35 years of vector control in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A critical assessment of vector control for dengue prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The partnership for dengue control - a new global alliance for the prevention and control of dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Treatment of dengue fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue research opportunities in the Americas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue fever: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Fluid intake and decreased risk for hospitalization for dengue fever, Nicaragua

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A retrospective analysis of dengue fever case management and frequency of co-morbidities associated with deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Comparison of the effects of oral hydration and intravenous fluid replacement in adult patients with non-shock dengue hemorrhagic fever in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Relevance of Non-communicable Comorbidities for the Development of the Severe Forms of Dengue: A Systematic Literature Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of the traditional and revised World Health Organization classifications of dengue cases in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Clinical presentation of dengue among patients admitted to the adult emergency department of a tertiary care hospital in Martinique: implications for triage, management, and reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Cerebellar Hemorrhage in a Patient during the Convalescent Phase of Dengue Fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Risk factors for hemorrhage in severe dengue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Pulmonary hemorrhage syndrome associated with an autochthonous case of dengue hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Prophylactic platelets in dengue: survey responses highlight lack of an evidence base

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Cardiac function in Vietnamese patients with different dengue severity grades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evaluation of cardiac involvement during dengue viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Lung in dengue: computed tomography findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Severity of acute hepatitis and its outcome in patients with dengue fever in a tertiary care hospital Karachi, Pakistan (South Asia)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue viral infection in children: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Lovastatin for adult patients with dengue: protocol for a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Self-reported pain intensity with the numeric reporting scale in adult dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Acute dengue virus myositis: a report of seven patients of varying clinical severity including two cases with severe fulminant myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue fever among Swedish tourists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Post-infectious fatigue syndrome in dengue infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Clinical deterioration in community acquired infections associated with lymphocyte upsurge in immunocompetent hosts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Optical coherence tomography patterns as predictors of visual outcome in dengue-related maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Acute kidney injury in dengue fever using Acute Kidney Injury Network criteria: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The dengue vaccine pipeline: Implications for the future of dengue control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A new moment for facing dengue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue: challenges for policy makers and vaccine developers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Efficacy of tetravalent dengue vaccine in Thai schoolchildren - Authors' reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Towards a global dengue research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

[Integrated strategy for dengue prevention and control in the Region of the Americas].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Vaccines against dengue: a review of current candidate vaccines at advanced development stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue research and training supported through the World Health Organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Effective control of dengue vectors with curtains and water container covers treated with insecticide in Mexico and Venezuela: cluster randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

A global compendium of human dengue virus occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

New insights into the immunopathology and control of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Inconclusive reverse transcription-PCR assay comparison for dengue virus detection and serotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Research on dengue during World War II

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Etiologies of the Experimental Dengues of Siler and Simmons *

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Evolution of dengue virus type 2 during two consecutive outbreaks with an increase in severity in southern Taiwan in 2001-2002.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue and chikungunya virus infection in man in Thailand, 1962-1964. IV. Epidemiologic studies in the Bangkok metropolitan area

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

HEMATOLOGIC FINDINGS IN THE 1960 HEMORRHAGIC FEVER EPIDEMIC (DENGUE) IN THAILAND.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Plasma leakage in dengue haemorrhagic fever.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

[Factors associated with maternal body mass index in a group of pregnant teenagers, Medellin, Colombia]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Improvement in hospital indicators after changes in dengue case management in Nicaragua.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Guillain-Barré syndrome following dengue fever

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Correction: Dengue Research Funded by the European Commission-Scientific Strategies of Three European Dengue Research Consortia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

7 January 2021

Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

7 January 2021

Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

7 January 2021

Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

7 January 2021

Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

7 January 2021

Association of human leukocyte antigen DQ1 and dengue fever in a white Southern Brazilian population

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

7 January 2021

Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

7 January 2021

Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2016.55

7 January 2021

Identifiers

DOI

10.1038/NRDP.2016.55

1 reference

12 November 2017

1 reference